research aimed at fighting cancer
Yale and the National Foundation for Cancer Research (NFCR) have established an NFCR Center for Anti-Cancer Drug Design and Discovery to develop new beta-peptide inhibitors that will play critical roles in the fight against many types of cancer.
Funded by a five-year, $750,000 grant from the NFCR, the center will be led jointly by Alanna Schepartz, the Milton Harris '29 Ph.D. Professor of Chemistry, and William Jorgensen, the Whitehead Professor of Chemistry.
"We are delighted that the NFCR has chosen to support Yale as a place where cutting-edge drug discovery research in chemistry is making, and will continue to make, an impact in the fight against cancer," said Provost Andrew Hamilton.
The new NFCR Center will work to develop a better understanding of how b-peptides can be designed to disrupt protein-protein interactions that transmit cell signals. When proteins behave abnormally, they often send incorrect signals that result in uncontrolled cell growth and division, and cancer. In their research, Schepartz and Jorgensen will focus on developing new, more effective approaches to inhibit these abnormal protein-protein interactions and thereby block transmission of cellular signals that lead to cancer growth.
Unlike the most commonly used small molecule inhibitors, b-peptides have a chemical structure very similar to that of their target proteins, allowing the drug to bind the target proteins more specifically and inhibit them more effectively. The Schepartz/Jorgensen team will use both cutting-edge experimental chemistry and computer modeling to design and optimize b-peptide inhibitors of a wide range of targets. Since b-peptides are stable within the human body, their research has the potential to create a completely new technology platform for more effective and long-lasting anticancer drugs.
"This new center provides a vital link among the worldwide network of NFCR- sponsored scientists that will significantly move our protein research to the forefront of cancer research," Schepartz said. "At Yale, we believe in the value of exploring every avenue in our quest to cure cancer, and with this partnership between NFCR and the university, we move one step closer to that goal."
The NFCR Center at Yale will collaborate with over 40 additional cancer researchers at universities and hospitals worldwide, and become a part of one of the largest cancer research networks in the world. Other NFCR Centers are located at Oxford University, Case Western Reserve University, University of Alabama-Birmingham, University of California-Berkeley, Dana Farber Cancer Center, University of Arizona, Freie Universität Berlin, and the Institute of Medicinal Biotechnology in Beijing to form a broader international collaborative network of top researchers.
"The NFCR Center for Anti-Cancer Drug Design and Discovery at Yale University will provide a new and vital link to the development of drug design that will undoubtedly lead to new, novel anticancer drugs that will help save lives," said Franklin Salisbury Jr., president of NFCR.
Since it's founding in 1973, NFCR has spent more than $230 million funding basic science cancer research and cancer prevention education focused on understanding how and why cells become cancerous. NFCR is dedicated to funding scientists who are discovering cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. For more information, visit www.NFCR.org or call (800) 321-CURE (2873).
T H I S
W E E K ' SS T O R I E S
Medical School receives $57.3 million NIH grant
Medical School receives $11.5 million to improve cancer diagnosis . . .
Museum technicians to show their own artworks at Open Studios
Student designs creative alternative to traditional construction fencing
MORE SCHOOL OF MEDICINE NEWS
Grant supports work predicting outcomes in cancer patients
High testosterone kills nerve cells, says study
Team learns why leptin has powerful effect on appetite
New biomarker predicts survival in colorectal cancer
Proteins shown to have surprising effects on autoimmune disease
Relationship between stress and disease to be explored
Conference looks at literature's power to ease children's fears
Study: Myo1f has key role in mobilizing immune system
Study explores cost-effectiveness of using prizes in drug therapy
Heart studies often don't include kidney patients at high riskLevin, Zedillo discuss the role of UNESCO at Paris event
'Women and Globalization' will be the topic of discussion . . .
Marketing executives and scholars to discuss latest trends
Australia's history and people are focus of film
Exhibit features paintings of England by Venetian artist 'Canaletto'
Lecture will examine the U.N. and 21st-century challenges
Lab talk
Play reading and talk will explore the romantic life of Benjamin Franklin
Tanner Lectures and related discussion to focus on humanities
'Crafting a Life' is the theme of this year's Law School reunions
Student research on early French songs culminates in . . .
Mutual interests
ALL gallery after-party celebrates artists in its newest exhibit and in CWOS
Campus Notes
Yale Books in Brief
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home